Form 8-K - Current report:
SEC Accession No. 0001628280-25-035506
Filing Date
2025-07-22
Accepted
2025-07-22 08:29:57
Documents
14
Period of Report
2025-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mdgl-20250717.htm   iXBRL 8-K 42818
2 EX-99.1 exhibit991-financingpr.htm EX-99.1 15648
6 imagea.jpg GRAPHIC 10012
  Complete submission text file 0001628280-25-035506.txt   203608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20250717.xsd EX-101.SCH 1803
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdgl-20250717_lab.xml EX-101.LAB 23471
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20250717_pre.xml EX-101.PRE 13598
16 EXTRACTED XBRL INSTANCE DOCUMENT mdgl-20250717_htm.xml XML 2953
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 251138750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)